5Yemisen M, Mete B, Tunali Y, et al. A meningitis case due to Stenotrophomonas mahophilia and review of the literature. Int J Infect Dis ,2008,12 : 125-127.
6Samonis G, Karageorgopoulos DE, Maraki S, et al.Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One, 2012,7 :e37375.
7Abbott IJ, Slavin MA, Turnidge JD, et al. Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment. Expert Rev Anti Infect Ther, 2011,9:471-488.
8Ansari SR, Hanna H, Hachem R, et al. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer,2007,109:2615-2622.
9Grate M,Dibama HM, Lafosse S, et al. Cationic compounds with activity against muhidrug-resistant bacteria: interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine. Clin Micmbiol Infect ,2010,16:432-438.
10Senol E. Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen. J Hosp Infect,2004,57:1-7.
